| Trial ID: | L4029 |
| Source ID: | NCT00607646
|
| Associated Drug: |
Dehydroepiandrosterone
|
| Title: |
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Dehydroepiandrosterone|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in level of catecholamines in blood from baseline, 6 weeks |
|
| Sponsor/Collaborators: |
Sponsor: University of Maryland, Baltimore | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
|
| Start Date: |
2010-10
|
| Completion Date: |
2018-10-09
|
| Results First Posted: |
|
| Last Update Posted: |
2019-09-12
|
| Locations: |
University of Maryland, Baltimore, Baltimore, Maryland, 21201, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00607646
|
